OR WAIT null SECS
September 24, 2009
Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO; more...
The US Food and Drug Administration sent Bayer Schering Pharma (Berlin) a Warning Letter on Aug. 5, 2009, citing deviations from current good manufacturing practice in the manufacture of nonsterile active pharmaceutical ingredients (APIs).
September 17, 2009
Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn Group appoints CEO of US business; more...
September 10, 2009
Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more...
September 03, 2009
The US Pharmacopeial Convention (USP) and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) signed a memorandum of understanding (MOU) last week.
Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...
September 02, 2009
Brief pharmaceutical news items for September 2009.
After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
An outstanding new book reviews alternative solvents with an eye to sustainable pharmaceutical processes.
A second-generation and green manufacturing process for testosterone provided economic and ecological benefits.